Your browser doesn't support javascript.
loading
Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.
Farrar, John T; Bilker, Warren B; Cochetti, Philip T; Argoff, Charles E; Haythornthwaite, Jennifer; Katz, Nathaniel P; Gilron, Ian.
Afiliação
  • Farrar JT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  • Bilker WB; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  • Cochetti PT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  • Argoff CE; Department of Neurology, Albany Medical Center, Albany, NY, United States.
  • Haythornthwaite J; Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Katz NP; Adjunct, Department of Anesthesia, Tufts University School of Medicine and Chief Science Officer, Analgesic Solutions, Boston, MA, United States.
  • Gilron I; Department of Anesthesiology and Perioperative Medicine, Queens University School of Medicine, Kingston, ON, Canada.
Pain ; 163(1): 47-57, 2022 Jan 01.
Article em En | MEDLINE | ID: mdl-34261978

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Dor Crônica Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Dor Crônica Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article